In its full extent, the range of BPC 157 therapy and its huge curing potential as a treatment (for review, see [1,3,4,5,6,8,9,32,33,34,92]) might largely override the range of the beneficial effects commonly reported with standard cytoprotective agents (for review, see [35,36,37,38,39,40,41,42]) (i.e., prostaglandins beneficial effects on the stomach [35], intestine [38], liver [130], pancreas [39], kidney [38,131], and heart [132])
GHK-Cu Research FAQs What is GHK-Cu
Understanding the mechanisms underlying METH-induced neurotoxicity is essential for developing effective treatment strategies to mitigate its devastating effects
We are a walk-in clinic, open 7 days a week with no appointment needed, so you can get answers and care on your schedule
Key Highlights
2017;28(9):212834 (Epub 2017/09/16)